Prudential Financial Inc Xeris Biopharma Holdings, Inc. Transaction History
Prudential Financial Inc
- $74.4 Billion
- Q2 2025
A detailed history of Prudential Financial Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 1,556,629 shares of XERS stock, worth $11.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,556,629
Previous 1,098,845
41.66%
Holding current value
$11.5 Million
Previous $6.03 Million
20.51%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding XERS
# of Institutions
224Shares Held
88.7MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$76 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$72.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$28.2 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$27.8 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...